Pura Vida Investments, LLC Cytom X Therapeutics, Inc. Transaction History

Pura Vida Investments, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$2.67 - $4.68 $258,736 - $453,515	-96,905 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$3.87 - $7.39 $9,543 - $18,223	-2,466 Reduced 2.48%	96,905 $420,000
Q3 2021 Nov 15, 2021	SELL	$4.32 - $6.43 $6,350 - $9,452	-1,470 Reduced 1.46%	99,371 $506,000
Q2 2021 Aug 16, 2021	SELL	$6.33 - $9.91 $643,362 - $1.01 Million	-101,637 Reduced 50.2%	100,841 $638,000
Q1 2021 May 12, 2021	BUY	$6.6 - $9.0 $1.34 Million - $1.82 Million	202,478 New	202,478 $1.57 Million

50.7M

112K

8.3K

Ticker CTMX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,950,200
Market Cap $69.9M
Description
CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...

Get notified when there are updates to the investment portfolio of Pura Vida Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Pura Vida Investments, LLC with notifications on news.